MU
Mohib Uddin
AstraZeneca FoU Göteborg, King's College London, University of Cambridge
0000-0002-2412-2657
About
BioMedical Scientist with Translational research experience specialising in novel pharmacotherapies for chronic inflammatory and immunological diseases.
I have established Academic collaborative links in Respiratory disease research and have been a recipient of a Research Fellowship Grant from the British Lung Foundation [P04/14].
Employment
-
AstraZeneca FoU Göteborg Translational Medical Scientist
Education
-
King's College London BSc [Hons.] PHARMACOLOGY
-
University of Cambridge PhD. MEDICINE
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Phosphatidylinositol kinases in GtoPdb v.2021.3 Save
- Delta subfamily (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database Save
- Phosphatidylinositol-4,5-bisphosphate 3-kinase family (version 2020.2) in the IUPHAR/BPS Guide to Pharmacology Database Save
- Phosphatidylinositol kinases (version 2020.2) in the IUPHAR/BPS Guide to Pharmacology Database Save
- Publisher Correction: Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly Save
- Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly Save
- Distinct Spatio-Temporal Dynamics of Tumor-Associated Neutrophils in Small Tumor Lesions. Save
- NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma. Save
- Unravelling neutrophil heterogeneity in chronic airway disease Save
- Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma Save